IndiaTickerSandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/StakeholdersBSE · exchange filing · pdf
Source filing Company dossier
Sandu Pharmaceuticals
BSE:SANDUPHQ · ISIN INE751D01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Sandu Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for To Place On Record The Demise Of Shri Umesh B. Sandu(DIN:01132141), Managing Director Of The Company, On 19Th June, 2026, And To Record The Board''s Appreciation For His Invaluable Contribution To The Company.BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-DemiseBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-CessationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner, Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT, Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As Per Physical Verification Of Goods.BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Audited Financials For The Q And Year Ended 31.03.2026BSE · financial results · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Statement Of Deviation And Variation Of Funds For Q Ended 31.03.2026BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 05Th May 2026BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for 1.Approval Of The Audited Financial Results For The Q And Year Ended 31.03.2026
2.To Recommend Final Dividend If Any.BSE · financial results · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Unaudited Financials For Quarter And Period Ended 31St December 2025BSE · financial results · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Statement Of Deviation And Variation For The Q Ended 31.12.2025BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for Approval Of Unaudited Financial Results For Q Ended 31St December 2025BSE · financial results · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Notice Intimating Discrepancies By Government Of Maharashtra Department Of Goods And Service Tax-Office Of The Deputy Commissioner Of The State Of GoaBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - : Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest And Properties Private Limited Persons Forming Part Of The 'Promoter/Promoter Group' Category To The 'Public' Category.BSE · exchange filing · pdf
Source filing Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing